1. Obesity Management

2. Dr Rajesh Jain MD Ex Medical officer-WHO Project Manager Diabetes Prevention Control Project, Uttar Pradesh, India National health Mission & World Diabetes foundation, Denmark

3. The Global Epidemic of Obesity

4. Obesity Is a Risk Factor for Many Comorbid Conditions

5. Life Expectancy Decreases as BMI Increases

6. Weight and Energy Balance: Current Perspective

7. Obesity: Imbalance of Energy Regulation

8. Feedback Regulation of Energy Metabolism

9. Phenotyping Patients With MHO: Key Clinical Parameters

10. Clinical and Functional Characteristics: MHO vs MUO

11. Weight Loss Improves Metabolic Risk Factors in Both Patients With MHO and Patients With MUO

12. Diabetes Prevention Program: Moderate Weight Loss Associated With Reduced Incidence of T2DM

13. Post-Hoc Analysis From Look AHEAD: The Importance of ≥10% Weight Loss

14. Look AHEAD: Intensive Lifestyle Intervention Associated With Reduced Incidence of Very High-Risk CKD

15. SCALE Obesity and Prediabetes Trial: Slower Onset to T2DM With Obesity Treatment

16. Weight Loss and Prevention of New Disease Onset: Results of the SOS Study

17. Weight Loss Strategies in Addition to Diet and Lifestyle Changes

18. Obesity Treatment Success: Percentage Body Weight Lost

19. Long-Term Anti-Obesity Drugs Approved in Europe and the US

20. Change in Weight From Baseline: Clinical Trial Data on 3 Drugs Approved by the EMA

21. Orlistat-Induced Weight Loss and Maintenance at 1 Year

22. COR-BMOD: Change in Body Weight, Naltrexone + Bupropion vs Placebo

23. SCALE: Change in Body Weight, Liraglutide vs Placebo

24. SCALE Maintenance: Patients Maintaining Run-In Weight Loss or Regaining ≥ 5%

25. The Conversation: Why Do You Eat
The Conversation: Why Do You Eat? Stratifying Patients to Weight-Loss Agents

26. AACE/TOS/ASMBS Guidelines: Criteria for Bariatric Surgery Recommendation

27. Summary and Conclusions

28. Abbreviations

29. Abbreviations (cont)

30. Abbreviations (cont)